Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

US National Institutes of Health (NIH), Department of Health and Human Services (HHS) grant open #PA-25-163

Response due Sep 07, 2026 · 00:00 UTC

Summary

This is a federal grant opportunity (Program Announcement PA-25-163) issued by the National Institutes of Health (NIH) under HHS. It solicits R01 research grant applications focused on alcohol treatment, pharmacotherapy, and recovery, with a clinical trial required as part of the funded research. The opportunity is open for an extended period from late 2024 through September 2026, reflecting a standing/recurring announcement structure typical of NIH program announcements.

What they want

Technical requirements

Clinical trial must be included as a required component of the research design
R01 grant mechanism applies

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

Minimal detail provided in the source text — full FOA (Funding Opportunity Announcement) should be reviewed on NIH Guide for complete eligibility, scope, and budget requirements
No dollar value, award ceiling, or number of awards stated in the provided text

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Alcohol Treatment, Pharmacotherapy, and Re…

Due Sep 07

Onboard ↗